Find information about the Cannatonic cannabis strain including reviews from other users, its most common effects, where to find it, and more. Cannatonic is a unique hybrid strain bred by Spanish seed bank Resin All values are averages. North Star CBD The History and Emergence of the CBD Cannabis Strains. Cannatonic Prominent terpenes in this hybrid strain include humulene, pinene, and guaiol which all share a reputation for anti-inflammatory. This high-CBD cannabis strain is ideal for first-timers and loved by those treating ailments like chronic pain, stress and migraines.
(The Marijuana – Strain) Cannatonic 5 All-Star
It is best used for relaxation and combating mild pain. This strain can cause dizziness and mild anxiety on rare occasions. The CBD content is quite high and ideal for those suffering from stress and lack of focus and energy. The combination gives it an earthy taste with flowery, sweet undertones. This is the best choice for those who want an uplifting, pleasant experience without the side effects of a high.
Harlequin This CBD strain is the perfect choice if you want to relieve daily, chronic pain without sedation and the dangerous side effects of painkillers. Harlequin was cultivated out of four different strains and has very strong sativa effects with a reliable 5: This strain may cause dry mouth and eyes in some cases. Hawaiian Dream One more CBD strain that focuses on reducing stress and giving emotional relief to consumers, Hawaiian Dream is the result of the combination of two strains and has a 2: Ideal for those who want to overcome draining anxiety and be able to work and be productive.
Island Sweet Skunk Mainly used for muscle spasms and anxiety relief, this CBD strain offers relaxation and a clear, calm mind without a strong high. You will still feel quite energetic and clear-headed. It might cause dry mouth and eyes. Jamaican Lion Best for the creative individual who wants a clear, focused mind together with the mind-expanding effects of sativa.
Jamaican Lion has an interesting tropical flavor with hints of sage and earthy undertones. This strain is very good for combating everyday chronic pain situations. It may cause dry mouth but leaves the head clear while containing just enough THC for a unique out-of-the-box experience that cheers you up. This is one of the best strains for consumers wishing to combat fatigue, inflammation, stress and muscle spasms. It has a very pleasant lemon and flowery taste with a quirky skunky undertone.
One of the most pleasant things about MediHaze is its intricate aroma and taste reminiscent of mint, spices and pine. Chances of side effects are very low.
Rafael is a great choice for people who are sensitive to THC but still need the beneficial effects of appetite increase, stress reduction and pain relief. Swiss Gold has a citrusy flavor with earthy undertones and a hint of a diesel aroma. It is often used for headaches, high stress levels and depression as it can increase happiness. It may cause light anxiety and dry eyes in some cases. ACDC has an earthy flavor that reminds one of citrus with woody undertones. Usually chosen for pain relief, you get a calming, soothing effect from ACDC.
Use may sometimes cause dry mouth and dizziness. Delicious and with a 2: At this ratio, a milder high is experienced with less of a sedation effect than found in a pure THC experience. There is a chance of having dry eyes and mouth after use, but this side effect is quite common in cannabis use. Avi-Dekel Avi-Dekel is mainly used to soothe digestive disorders, decrease inflammation and help patients sleep easier. Use may cause dry mouth and mild anxiety in some cases. The taste is earthy with woody and pine undertones.
Avi-Dekel is best taken at the end of your day. It is most often chosen by those looking to relax into sleep, usually because anxiety, muscle spasms or pain keeps them from doing so naturally. While this strain can sometimes cause dry mouth, it is quite popular among those who experience anxiety attacks with regular medicinal cannabis use and THC highs. This particular hybrid is well known for its citrusy aroma and earthy tang when it comes to flavor profile.
Often taken by people suffering from anxiety disorders, Canna-Tsu offers a clear-headed high that allows the imbiber to focus on chores and work while distracting from pain and stress. This strain is good for taking in the morning if needed. This CBD strain has a quite strong effect compared to others with less THC but offers a lot more clarity than straight marijuana use. The effects are generally calming, offering an euphoric feeling and pain relief. Ideal for those who want to switch steadily from marijuana to CBD-rich strains, Cannatonic has an earthy flavor reminiscent of pine.
Dieseltonic This CBD strain is quite potent with a 1: Often chosen for mental disorders like depression and anxiety disorders, Dieseltonic gives more mental clarity than typical THC-dominant strains, giving better focus and a happy euphoria.
The taste is quite particular, reminding one of diesel and orange, so it is best to be prepared for a unique flavor experience. Dieseltonic may cause dry eyes and mouth.
GI GI is one of the top high CBD strains if you want lots of benefits but a very low almost null chance of a high. The pleasant citrus flavor offers a mix of lemon and lime. This is best for people who want no high, just relief and relaxation. With an earthy flavor with citrusy undertones and a spicy sensation, Harle-Tsu is liked by many who wish to have a relaxing experience combined with pain relief and an uplifting effect. There is no serious chance of getting a real high or psychoactive effects.
You may experience dry mouth, but this is a common, harmless side effect. Best used for treating pain, anxiety and inflammation, some psychoactive effects can be expected, depending on your sensitivity. With a pleasant flavor reminiscent of berries and woody, earthy undertones, Maui Bubble Gift is the choice of many who want to lower their THC intake.
Midnight This CBD strain was specially developed to combat nausea and lack of appetite. It may also help with insomnia and inability to calm down. With a taste reminiscent of flowers, especially lavender and rose, Midnight is quite popular. Use may sometimes cause dry mouth and eyes, but these side effects are quite common in cannabis use and are harmless.
These benefits include pain relief, reduction of inflammation and the ability to relax into a happy, euphoric state. Nebula II has a sweet, honey-like taste that makes it quite popular. This is an ideal choice for those new to CBD-rich strains. OG Ringo Earthy and nutty with woody undertones, OG Ringo is commonly considered a tasty strain that delivers a euphoric, happy high with more mental clarity than do THC-dominant strains. It may cause a spark of creativity and focus in some while combating the symptoms of depression and anxiety for many.
OG Ringo is often chosen for mental illnesses to combat a drop in productivity and happiness. One to One This strain offers an average 1: Purple Cheese With a flavor strongly reminiscent of cheese and blueberries, Purple Cheese has a high CBD content and is favored by people seeking relaxation.
The high and effect might be stronger than in other high CBD strains, so it is best used at night for people who need to wind down, get rid of bad thoughts and be able to relax into sleep in a euphoric state. Use may cause dry mouth. The taste is earthy and reminds one of a mix of citrus and pine. This is best chosen by those wishing to relax and relieve pain without as much of a high and its consequences.
Trident The aroma of these buds can be quite pungent but is pleasantly sweet and earthy. Trident has a double CBD to THC ratio, which combats pain and stress while offering only a mild, more manageable high. Best used late at night and not before a hopefully productive day. Valentine X Able to spark creative thoughts and offering a deliciously fruity experience, Valentine X is becoming increasingly popular.
Often chosen for treatment of cancer patients, epileptic children and adults as well as inflammation, Valentine X has no psychoactive effects. VCDC is designed to be good for cancer patients seeking relief from nausea and pain but is also popular for anxiety disorders and for combating stress. Identifying differences in use patterns between migraine, headache, arthritis, and chronic pain syndromes may be helpful in optimizing crossbred cannabis strains, synergistic biochemical profiles, or dosing differences between these pain subsets.
This suggests that most headaches being treated with medicinal cannabis were likely of migrainous pathophysiology. Hybrid cannabis strains were preferred across most pain groups. Since migraines also involve nausea and vomiting, the potent antiemetic properties of THC may be a reason for this preference.
There are several limitations to the data in this study, and these results require further confirmation with more sophisticated prospective study methods. However, these results may provide early insight and a framework for direction into optimizing crossbred cannabis strains, synergistic biochemical profiles, dosing, and patterns of use that may be of clinical benefit in the treatment of headache and migraine, as well as other chronic pain syndromes. PL designed the survey, coordinated its administration and data collection, and assisted in writing of the manuscript.
JE conducted the biochemical analysis of cannabis strain cannabinoid and terpene compositions, and reviewed the manuscript. OH conducted the statistical analysis of the data and assisted with writing of the correlating statistical analysis data in the manuscript. All authors read and approved the final manuscript. Vice-President of Patient Research and Access for Tilray, ownership interest stocks, stock options, or other ownership interest excluding diversified mutual funds , salary.
Vice-President and Chief Science Officer for Tilray, ownership interest stocks, stock options, or other ownership interest excluding diversified mutual funds , salary. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. National Center for Biotechnology Information , U.
Journal List J Headache Pain v. Published online May Author information Article notes Copyright and License information Disclaimer. Received Apr 13; Accepted May 4. This article has been cited by other articles in PMC. Abstract Background Medicinal cannabis registries typically report pain as the most common reason for use.
Methods Via electronic survey in medicinal cannabis patients with headache, arthritis, and chronic pain, demographics and patterns of cannabis use including methods, frequency, quantity, preferred strains, cannabinoid and terpene profiles, and prescription substitutions were recorded. Results Of patients, 21 illnesses were treated with cannabis. Conclusions Chronic pain was the most common reason for cannabis use, consistent with most registries. Background The legal use of medicinal cannabis continues to increase globally, including the United States.
Methods Appropriate Investigational Review Boards approved the survey. Results Of the patients included in the survey, Table 1 Primary illness treated with medicinal cannabis. Open in a separate window. Table 2 Headache as primary symptom treated with medicinal cannabis among various primary illnesses reported. Table 5 Preferred medicinal cannabis types and strains in all non-headache groups, including patients with headache as primary symptom.
Table 6 Preferred medicinal cannabis types and strains in all non-headache groups, excluding patients with headache as primary symptom. Cannabis extracts drops, capsules Total Hybrid Indica Sativa 3: THC Headache as primary symptom Discussion The neurobiological pathways of cannabinoids and pain, including migraine and headache, have been detailed, summarized and should be reviewed [ 1 , 2 , 51 , 65 , 68 — 70 ].
Conclusions Chronic pain was the most common reason for use of medicinal cannabis, consistent with the statistics of most registries. Contributor Information Eric P. Cannabis for migraine treatment: An historical and scientific review. Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: Marijuana in ancient Greece and Rome?
Emir J Food Agric. Cannabinoids and hallucinogens for headache. Hallucinogens and cannabinoids for headache. Observations on the medical properties of the cannabis sativa of India.
Cannabis Indica in the treatment of migraine. Osler W, McCrae T. The principles and practice of medicine. Remarks on the value of Indian hemp in the treatment of a certain type of headache.
On the use of belladonna and cannabis Indica by the rectum in gynecological practice. Boston Med Surg J. On the therapeutic uses and toxic effects of cannabis Indica.
Migraine associated with menstruation. J Am Med Assoc. Therapeutic uses of Cannabis. Harwood Academic Publishers; Cannabinoids for the treatment of chronic non-cancer pain: Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol. Cannabinoids for medical use: The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: J Oral Facial Pain Headache.
Committee of the Health Effects of Marijuana. An evidence review and research agenda. The health effects of cannabis and cannabinoids. The current state of evidence and recommendations for research. The National Academies Press; Pharmacological management of chronic neuropathic pain: History of cannabis as a medicine: Baron EP Medicinal properties of cannabinoids, terpenes and flavonoids in cannabis, and potential roles in migraine, headache, and pain: Characteristics of adults seeking medical marijuana certification.
Hazekamp A, Heerdink ER. The prevalence and incidence of medicinal cannabis on prescription in the Netherlands. Eur J Clin Pharmacol. Medical Marijuana Registry Statistics.
Colorado Department of Health and Environment. Accessed 1 Dec Minnesota Department of Health. Medical cannabis patient registry program. Illinois Department of Public Health. Hawaii Department of Health. Oregon Medical Marijuana Program Statistics. State of New Jersey Department of Health. Arizona Department of Health Services. Grinspoon L, Bakalar JB. Cannabinoids block release of serotonin from platelets induced by plasma from migraine patients. Int J Clin Pharmacol Res.
Migraine headaches and drug abuse. Results of a standardized survey on the medical use of cannabis products in the German-speaking area. Pharmacological treatment of headache using traditional Persian medicine. The endocannabinoid system and migraine. Effects of medical marijuana on migraine headache frequency in an adult population. On the physical and medicinal qualities of Indian hemp Cannabis Indica ; with observations on the best mode of administration, and cases illustrative of its powers.
Dublin J Med Sci. On some of the therapeutical uses of Indian hemp. A handbook of therapeutics. Clinical and physiological notes on the action of cannabis Indica. On the therapeutic value of Indian hemp. Schaffer Library of Drug Policy; Therapeutic use of cannabinoids - dose finding, effects, and pilot data of effects in chronic migraine and cluster headache.
Cluster attacks responsive to recreational cannabis and dronabinol. Use of cannabis among cluster headache sufferers. J Neurol Neurosurg Psychiatry. J Drug Policy Anal 4 1: Nabilone for the treatment of medication overuse headache: Are cannabis-based chemicals helpful in headache? The perceived effects of smoked cannabis on patients with multiple sclerosis. The use of cannabis for headache disorders. Global Clinical Director Solvay Pharmaceuticals. Accessed 15 Dec A self-administered screener for migraine in primary care: Cannabinoid CB1 receptor activation inhibits trigeminovascular neurons.
J Pharmacol Exp Ther. Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. Serrano A, Parsons LH. Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.
The endocannabinoid system and its relevance for nutrition. Efficacy in CB1 receptor-mediated signal transduction. The endocannabinoid system as a key mediator during liver diseases: Mechanism of extracellular signal-regulated kinase activation by the CB 1 cannabinoid receptor.
The orphan receptor GPR55 is a novel cannabinoid receptor. An introduction to the endocannabinoid system: Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
Handb Exp Pharmacol Plant, synthetic, and endogenous cannabinoids in medicine. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Guindon J, Hohmann AG. The endocannabinoid system and pain. Guindon J, Beaulieu P. The role of the endogenous cannabinoid system in peripheral analgesia. Is there any clinically relevant cannabinoid-induced analgesia? Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses.
International Union of Basic and Clinical Pharmacology. Cannabinoid receptors and their ligands: Katona I, Freund TF. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Cannabis and the brain. The use of marijuana or synthetic cannabinoids for the treatment of headache.
Signaling via CNS cannabinoid receptors. Cannabinoid-induced immune suppression and modulation of antigen-presenting cells. Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice. Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors. Eur J Pharm Sci. An overview of major and minor phytocannabinoids. Neuropathology of drug addictions and substance misuse, Volume 1: Cannabinoid activation of peroxisome proliferator-activated receptors: Cannabinoid actions at TRPV channels: Acta Physiol Oxf ; Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
Direct inhibition by cannabinoids of human 5-HT3A receptors: Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors.
Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. Neuroprotective antioxidants from marijuana.
Ann N Y Acad Sci. The cannabinoid receptor agonist WIN 55, mesylate blocks the development of hyperalgesia produced by capsaicin in rats. Phytochemical and genetic analyses of ancient cannabis from Central Asia. Cannabinoids in the management of difficult to treat pain.
Ther Clin Risk Manag. The endocannabinoid system, cannabinoids, and pain. Rambam Maimonides Med J. Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI , or naloxone in mice.
The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Antinociceptive synergy between delta 9 -tetrahydrocannabinol and opioids after oral administration. Synergistic interactions between cannabinoid and opioid analgesics.
Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain. Brain Res Mol Brain Res. Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.
Cannabinoids as pharmacotherapies for neuropathic pain: The endocannabinoid system as an emerging target of pharmacotherapy. The analgesic properties of deltatetrahydrocannabinol and codeine. Analgesic effect of deltatetrahydrocannabinol.
DeltaTHC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief. Curr Med Res Opin. Deltatetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. Eur Arch Psychiatry Clin Neurosci. Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Barrie N, Manolios N. The endocannabinoid system in pain and inflammation: Evaluation of the cyclooxygenase inhibiting effects of six major cannabinoids isolated from cannabis sativa.
Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Cannabinoid transmission and pain perception. Pharmacological evaluation of the natural constituent of cannabis sativa, cannabichromene and its modulation by Delta 9 -tetrahydrocannabinol. Delta 9-tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-independent mechanism. Cannabinoid CB2 receptors regulate central sensitization and pain responses associated with osteoarthritis of the knee joint.
Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis. Rheumatology Oxford ; CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Cannabinoids as novel anti-inflammatory drugs. Medical marijuana and chronic pain: Curr Pain Headache Rep. Anesthesiol Res Pract Tetrahydrocannabinol THC for cramps in amyotrophic lateral sclerosis: Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia. Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats.
The neurobiology of cannabinoid analgesia. Smoked cannabis for chronic neuropathic pain: Low-dose vaporized cannabis significantly improves neuropathic pain. A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. Smoked medicinal cannabis for neuropathic pain in HIV: Cannabis in painful HIV-associated sensory neuropathy: Smoked cannabis for spasticity in multiple sclerosis: Efficacy of inhaled cannabis on painful diabetic neuropathy.
Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. Antinociceptive, subjective and behavioral effects of smoked marijuana in humans.
Cannabinoid-opioid interaction in chronic pain. The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: J Pain Palliat Care Pharmacother. Cannabis for the Management of Pain: Cannabis use in patients with fibromyalgia: Sativex successfully treats neuropathic pain characterised by allodynia: Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine Sativex in the treatment of pain caused by rheumatoid arthritis.
Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms.
Initial experiences with medicinal extracts of cannabis for chronic pain: A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex R nabiximols Mult Scler.
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: J Pain Symptom Manag.
Cannabinoids in multiple sclerosis CAMS study: Role of cannabinoids in multiple sclerosis. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis CAMS study: Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis.
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on patients. Lakhan SE, Rowland M. Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract Cannador for postoperative pain management.
N Engl J Med. Antiemetics in patients receiving chemotherapy for cancer: Inhalation marijuana as an antiemetic for cancer chemotherapy. N Y State J Med. Deltatetrahydrocannabinol in cancer chemotherapy: Deltatetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy.
A comparison with prochlorperazine and a placebo. Cannabis and cancer chemotherapy: Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.
Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine. Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15 mg of delta 9-tetrahydrocannabinol in cancer chemotherapy.
Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy. Niiranen A, Mattson K. A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy. Am J Clin Oncol. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.
Review of cannabinoids and their antiemetic effectiveness. Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy. Two-pronged study of tetrahydrocannabinol THC prevention of vomiting for cancer chemotherapy. Dronabinol and prochlorperazine alone and in combination as antiemetic agents for cancer chemotherapy.
Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting. Recent clinical experience with dronabinol. Gonzalez-Rosales F, Walsh D. Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol dronabinol J Pain Symptom Manag. Delatatetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation. Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system.
Regulation of nausea and vomiting by cannabinoids. Cannabinoids for control of chemotherapy induced nausea and vomiting: Sutton IR, Daeninck P. Cannabinoids in the management of intractable chemotherapy-induced nausea and vomiting and cancer-related pain.
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents. Management of chemotherapy-induced nausea and vomiting. A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
Eur J Cancer Clin Oncol. Antiemetic efficacy of smoked marijuana: Therapeutic use of cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: Eur J Cancer Care Engl ; Musty R, Rossi R. Effects of smoked cannabis and oral deltatetrahydrocannabinol on nausea and emesis after cancer chemotherapy: Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting.
Amelioration of cancer chemotherapy-induced nausea and vomiting by deltatetrahydrocannabinol. Targeting the endocannabinoid system with cannabinoid receptor agonists: Nabilone as effective therapy for intractable nausea and vomiting in AIDS. Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: An efficient new cannabinoid antiemetic in pediatric oncology.
Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. Effect of the synthetic cannabinoid dronabinol on central pain in patients with multiple sclerosis--secondary publication. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis?
Randomised double blind placebo controlled crossover trial. Nabilone for the treatment of pain in fibromyalgia. The analgesic effect of oral deltatetrahydrocannabinol THC , morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions.
Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain--a randomized controlled trial. Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain: An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain.
Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: Clinical experience with nabilone for chronic pain. Hamann W, di Vadi PP. Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors. Experience with the synthetic cannabinoid nabilone in chronic noncancer pain. Nabilone in the treatment of multiple sclerosis. Expert Committee on Drug Dependence.
Accessed 20 Dec Accessed 23 Apr An orally active Cannabis extract with high content in cannabidiol attenuates chemically-induced intestinal inflammation and hypermotility in the mouse. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Analgesic and antiinflammatory activity of constituents of cannabis sativa L. The medicinal uses of cannabis and its constituents. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw. Naunyn Schmiedeberg's Arch Pharmacol. Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. Free Radic Biol Med. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: Zhornitsky S, Potvin S.
Banana Haze is a highly potent medicinal marijuana strain that is revered for both its . Cannatonic, most famous for its high CBD content, is an excellent choice for patients . it is clear that this combination of Sour Diesel, Sensi Star, and OG K.. . powers of CBD with the psychoactive relief of THC w THC. CBD. 5. In recent years, Cannabis high CBD strains have rapidly become one of the With all the high CBD strains available it is becoming exceedingly difficult to find the . strains and has very strong sativa effects with a reliable CBD to THC ratio. . switch steadily from marijuana to CBD-rich strains, Cannatonic has an earthy. After all, CBD helps counteract the psychoactive effects of THC and can even reduce the . 5 – Cannatonic (The All-Star Marijuana Strain).